Private equity group Horizon Capital has invested in Viseven, a global pharma marketing technology provider founded in Ukraine, through the $328 million Horizon Capital Growth Fund IV.
Horizon didn't say how much it invested in Viseven, which was founded in Ukraine in 2009 and has since grown to include more than 700 employees in Europe, Asia, and North and South America.
